COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-79

Condition:   COVID-19 Interventions:   Drug: Apixaban 2.5 MG;   Drug: Apixaban 5MG;   Drug: Aspirin;   Drug: Placebo Sponsors:   Frank C Sciurba;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials